These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12930442)

  • 1. Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model.
    Zellweger T; Kiyama S; Chi K; Miyake H; Adomat H; Skov K; Gleave ME
    BJU Int; 2003 Sep; 92(4):463-9. PubMed ID: 12930442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin.
    Zellweger T; Chi K; Miyake H; Adomat H; Kiyama S; Skov K; Gleave ME
    Clin Cancer Res; 2002 Oct; 8(10):3276-84. PubMed ID: 12374699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells.
    Kyprianou N; King ED; Bradbury D; Rhee JG
    Int J Cancer; 1997 Jan; 70(3):341-8. PubMed ID: 9033638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models.
    Miyake H; Nelson C; Rennie PS; Gleave ME
    Cancer Res; 2000 May; 60(9):2547-54. PubMed ID: 10811138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of cell death in LNCaP cells by overexpression of clusterin].
    Xin DQ; Zhu XH; Ai JK; Na YQ; Guo YL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 36(2):154-8. PubMed ID: 15100733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen.
    Miyake H; Hara I; Gleave ME; Eto H
    Prostate; 2004 Dec; 61(4):318-23. PubMed ID: 15389725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer.
    Miyake H; Nelson C; Rennie PS; Gleave ME
    Cancer Res; 2000 Jan; 60(1):170-6. PubMed ID: 10646870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different docetaxel-induced apoptotic pathways are present in prostate cancer cell lines LNCaP and PC-3.
    Muenchen HJ; Poncza PJ; Pienta KJ
    Urology; 2001 Feb; 57(2):366-70. PubMed ID: 11182366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-induced apoptosis of human prostate cancer cells is independent of mutant p53 overexpression.
    Kyprianou N; Rock S
    Anticancer Res; 1998; 18(2A):897-905. PubMed ID: 9615738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin.
    Zellweger T; Miyake H; July LV; Akbari M; Kiyama S; Gleave ME
    Neoplasia; 2001; 3(4):360-7. PubMed ID: 11571636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
    Miyake H; Nelson C; Rennie PS; Gleave ME
    Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer.
    Scaltriti M; Brausi M; Amorosi A; Caporali A; D'Arca D; Astancolle S; Corti A; Bettuzzi S
    Int J Cancer; 2004 Jan; 108(1):23-30. PubMed ID: 14618611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of clusterin gene into human renal cell carcinoma cells enhances their resistance to cytotoxic chemotherapy through inhibition of apoptosis both in vitro and in vivo.
    Hara I; Miyake H; Gleave ME; Kamidono S
    Jpn J Cancer Res; 2001 Nov; 92(11):1220-4. PubMed ID: 11714447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer.
    Gleave M; Miyake H
    World J Urol; 2005 Feb; 23(1):38-46. PubMed ID: 15770517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy.
    July LV; Akbari M; Zellweger T; Jones EC; Goldenberg SL; Gleave ME
    Prostate; 2002 Feb; 50(3):179-88. PubMed ID: 11813210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clusterin overexpression in both malignant and nonmalignant prostate epithelial cells induces cell cycle arrest and apoptosis.
    Scaltriti M; Bettuzzi S; Sharrard RM; Caporali A; Caccamo AE; Maitland NJ
    Br J Cancer; 2004 Nov; 91(10):1842-50. PubMed ID: 15494717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens.
    Bettuzzi S; Davalli P; Astancolle S; Carani C; Madeo B; Tampieri A; Corti A
    Cancer Res; 2000 Jan; 60(1):28-34. PubMed ID: 10646846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes.
    Yamanaka K; Rocchi P; Miyake H; Fazli L; So A; Zangemeister-Wittke U; Gleave ME
    BJU Int; 2006 Jun; 97(6):1300-8. PubMed ID: 16686729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line.
    Mizokami A; Gotoh A; Yamada H; Keller ET; Matsumoto T
    J Urol; 2000 Sep; 164(3 Pt 1):800-5. PubMed ID: 10953159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT-resistant PC-3 and CPT-sensitive LNCaP cells.
    Mizutani K; Matsumoto K; Hasegawa N; Deguchi T; Nozawa Y
    Exp Oncol; 2006 Sep; 28(3):209-15. PubMed ID: 17080014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.